Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects.
about
Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's DiseaseElectron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial BioenergeticsMicroglial Activation in the Pathogenesis of Huntington's Disease.High-Fat Diet and Voluntary Chronic Aerobic Exercise Recover Altered Levels of Aging-Related Tryptophan Metabolites along the Kynurenine Pathway.Neurorestorative targets of dietary long-chain omega-3 fatty acids in neurological injury.Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.Gender-Specific Degeneration of Dementia-Related Subcortical Structures Throughout the Lifespan.Kynurenines and other novel therapeutic strategies in the treatment of dementia.Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis.Manipulation with kynurenines: a possible tool for treating neurodegenerative diseases?Gene-metabolite profile integration to understand the cause of spaceflight induced immunodeficiency.
P2860
Q26781849-A74C58F3-A0CA-450A-A747-4A8E8FE6BC4FQ26795417-59E28D7D-29E7-4030-81CA-00610C355529Q33809556-4B26D7F4-1477-4F3E-9DE7-68654FF113E2Q33854563-9C98C90F-F1D9-48C2-A14C-12C035BB7C6DQ34282985-FB681FF7-A4A6-48A6-8644-F7D0587D4019Q38063779-D734952F-C482-4801-AE09-E4E3BD9F2C73Q38253558-2782945E-4F61-4B29-99C1-0A24FAE359B0Q38322773-19752A69-5AFF-4B32-B08A-5B46F9896DFEQ38632327-04399C7C-DE4D-4720-8327-9967B67A71E6Q38830945-CA00EE91-0255-446E-AFE1-5C0DEEF96D45Q38993591-9E33C13B-70CE-4600-AF3E-B7EC45627640Q39315645-24C958A6-5A43-4029-8FA5-273149CCEB1EQ39399401-534F85F8-1468-4F2C-A260-E5D04A68A50DQ51165149-6AB81B9C-6DE3-45ED-B0B8-8E9C073D0C32Q54755426-631E1D31-A872-47E4-8FBC-87AF704D4D35Q55096076-17B35829-1027-4D75-ADA6-03072D3E4E54
P2860
Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mitochondrial disturbances, tr ...... : medicinal chemistry aspects.
@en
Mitochondrial disturbances, tr ...... : medicinal chemistry aspects.
@nl
type
label
Mitochondrial disturbances, tr ...... : medicinal chemistry aspects.
@en
Mitochondrial disturbances, tr ...... : medicinal chemistry aspects.
@nl
prefLabel
Mitochondrial disturbances, tr ...... : medicinal chemistry aspects.
@en
Mitochondrial disturbances, tr ...... : medicinal chemistry aspects.
@nl
P2093
P50
P1476
Mitochondrial disturbances, tr ...... n: medicinal chemistry aspects
@en
P2093
P304
P356
10.2174/092986712800167365
P577
2012-01-01T00:00:00Z